Samsung Biologics Co.,Ltd.
207940
Ранг среди акций
#498
Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon,... Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon, South Korea, provides contract services for biopharmaceutical products. The company's operations are divided into two main segments: Contract Manufacturing Organization (CMO) and Contract Development Organization (CDO). Its CDO services cover areas such as cell line development, optimization of upstream and downstream processes, and the formulation of analytical methods and final products. For CMO, the company offers aseptic filling, lyophilization, finishing, storage, shipping, and various associated support services. Additionally, it delivers comprehensive quality assurance, quality control, biosafety, and analytical testing. Samsung Biologics is also involved in creating and launching biosimilar drugs, alongside manufacturing mammalian cell-based antibody medications.
Цена акции
$1,028.49
Рыночная капитализация
$47.88B
Изменение (1 день)
-3.67%
Изменение (1 год)
-18.37%
Страна
KR
Торговля Samsung Biologics Co.,Ltd. (207940)
Категория
Healthcare
Коэффициент P/B для Samsung Biologics Co.,Ltd. (207940)
Коэффициент P/B на October 2026 TTM: 7.59
Согласно последним финансовым отчетам и цене акций Samsung Biologics Co.,Ltd., текущий коэффициент P/B (TTM) составляет 7.59. В конце 2024 он составлял 6.19.
История P/B для Samsung Biologics Co.,Ltd. с 2014 по 2026
Коэффициент P/B в конце каждого года
| Год | P/B | Изменить |
|---|---|---|
| 2026 (TTM) | 7.59 | -27.89% |
| 2025 | 10.52 | 69.82% |
| 2024 | 6.19 | 8.43% |
| 2023 | 5.71 | -11.02% |
| 2022 | 6.42 | -46.93% |
| 2021 | 12.10 | 0.73% |
| 2020 | 12.01 | 80.63% |
| 2019 | 6.65 | 10.48% |
| 2018 | 6.02 | -8.12% |
| 2017 | 6.55 | 197.83% |
| 2016 | 2.20 | -43.49% |
| 2015 | 3.89 | -78.44% |
| 2014 | 18.05 | 0.00% |
Коэффициент P/B для аналогичных компаний или конкурентов
| Компания | P/B | Разница P/B | Страна |
|---|---|---|---|
| 6.6964 | -11.72% |
US
|
|
| 13.6307 | 79.69% |
US
|
|
| 4.4521 | -41.31% |
AU
|
|
| 4.2241 | -44.31% |
BE
|
|
| 6.3632 | -16.11% |
NL
|
